New chemical modification improves effectiveness and safety of ASO therapy for CNS diseases

FHS
May 23, 2024
2:48 pm

Diseases that affect the brain and spinal cord can be particularly devastating, and finding new and more effective ways to treat these conditions is an important goal for researchers and clinicians alike.

Aceragen to pull out of Nasdaq and liquidate assets, ending tumultuous journey for Idera Pharma

Aceragen is set to cease its Nasdaq listing, the next step for the beleaguered company whose assets are slated to be liquidated. The company has

August 8, 2023

Study investigates the serious health issues faced by Aboriginal and Torres Strait Islander people

A landmark research project will place health workers in Indigenous communities across Queensland to study the long-term wellbeing of Aboriginal and Torres Strait Islander families.

August 1, 2023

Innovative modeling framework to reconstruct data on fertility and education

IIASA researchers have introduced an innovative methodology for reconstructing data on fertility and education, particularly in developing countries with inconsistent or unreliable data sets.

December 5, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.